Centogene sets IPO pricing terms
Centogene, a company focused on rare diseases, is seeking to raise about $60 million for its IPO after pricing its 4 million shares at a price range between $14 and $16 per share. Centogene is planning on trading the stock on the NASDAQ under the ticker symbol "CNTG." SVB Leerink and Evercore ISI are the lead underwriters. Centogene's backers include TVM Capital Life Science.
29 October 2019•3 mins read
